Detalles de la búsqueda
1.
Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study.
J Am Geriatr Soc
; 55(7): 1015-22, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17608873
2.
[China coronary secondary prevention study: analysis of patients with different myocardial infarction history].
Zhonghua Nei Ke Za Zhi
; 45(1): 21-4, 2006 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-16624082
3.
[The beneficial effects of lipid-lowering therapy with xuezhikang on cardiac events and total mortality in coronary heart disease patients with or without hypertension: a random, double-blinded, placebo controlled clinical trial].
Zhonghua Xin Xue Guan Bing Za Zhi
; 34(10): 890-4, 2006 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-17217713
4.
[China coronary secondary prevention study (CCSPS): outcomes from analysis of coronary heart disease patients with diabetes].
Zhonghua Xin Xue Guan Bing Za Zhi
; 33(12): 1067-70, 2005 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-16563271
5.
Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS).
J Cardiovasc Pharmacol
; 49(2): 81-4, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17312447
Resultados
1 -
5
de 5
1
Próxima >
>>